U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748559) titled 'Impact of High-Oleic Palm Oil Consumption on Cardiovascular Biomarkers in Adults in Bogota' on July 27.
Brief Summary: This randomized clinical trial aims to evaluate the effects of refined high-oleic palm oil consumption on cardiovascular risk biomarkers and insulin resistance in healthy adults. Participants will be randomly assigned to two groups to consume either high-oleic palm oil or olive oil for four months in typical domestic preparations.
Study Start Date: Oct. 22, 2024
Study Type: INTERVENTIONAL
Condition:
Insulinemic Response
Type 2 Diabetes (Adult Onset)
Hyperglycaemia (Diabetic)
Hyperlipidaemia
Intervention:
OTHER:...